Latest Senior Health news from across the web.
Many enrollees don’t know they’ll need to report work, education or volunteer hours starting in less than six months in order to stay covered, according to a recent survey from the Health Management Academy.
Read full article →(MedPage Today) -- Fewer toddlers developed egg allergies after guidelines changed to recommend introducing egg products in infancy, large population-based studies from Australia showed. As the proportion of infants introduced to egg by 6 months...
Read full article →(MedPage Today) -- Note that some links may require registration or subscription. Harvard University professor Robert Coles, MD, the psychiatrist and Pulitzer Prize-winning author who championed the cause of children grappling with poverty and...
Read full article →Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s robotics strategy.
Read full article →The future of healthcare savings won’t come from bigger discounts—it will come from better alignment, accountability, and member experience.
Read full article →Surgery avoidance isn’t enough. Outcomes optimization is critical to your cost of care efforts.
Read full article →(MedPage Today) -- NEW ORLEANS -- Participants with obesity achieved weight loss on par with bariatric surgery and had improvements in two obesity-related conditions while taking a once-weekly investigational triple hormone receptor agonist...
Read full article →(MedPage Today) -- NEW ORLEANS -- Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in adults with type 2 diabetes, the phase III TRANSCEND-T2D-1 trial showed...
Read full article →(MedPage Today) -- NEW ORLEANS -- Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international ACHIEVE-5 trial showed. In patients already taking background insulin glargine...
Read full article →(MedPage Today) -- "I realize we're close to beer time here -- promise to at least give you something very scintillating." -- Paul Richardson, MD, of the Dana-Farber Cancer Institute in Boston, before presenting trial results for a novel oral...
Read full article →(MedPage Today) -- LONDON -- Late-breaking abstracts presented at the European Alliance of Associations for Rheumatology's (EULAR) annual meeting, held here last week, addressed a wide range of clinical concerns and suggested that patients and...
Read full article →(MedPage Today) -- NEW ORLEANS -- Petrelintide, an investigational long-acting amylin analog, induced significant weight loss with minimal side effects in the global phase II ZUPREME-1 study. By week 28, all five investigational doses of petrelintide...
Read full article →